cbdMD, Inc. beat EPS estimates 0% of the time across 1 reported quarters (0 beats, 1 misses), averaging -60.0% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q3 FY26 | not reported | $-0.11 | not reported | not reported | |
| Q2 FY26 | $-0.05 | $-0.08 | -60.0% | Miss |
Back to YCBD overview · YCBD holders · YCBD KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.